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Abstract 
 
Oxidative stress in utero–placental tissues plays an important role in the development of placental-related diseases. Maternal 
hiperhomocysteinemia is associated with placental mediated diseases, such as preeclampsia, spontaneous abortion and placental 
abruption. The aim of our study is to appreciate the clinical usefulness of the dosage serum homocysteine and malondialdehyde, as 
an oxidative stress marker, in the pregnancies complicated with risk of abortion or preterm birth. 
The study was performed at the Obstetric Gynecology Clinical Hospital Oradea from December 2009 until April 2010. It included 18 
patients with risk of abortion (group 1), 22 with preterm birth (group 2). The results were compared with a control group composed by 
14 healthy pregnant women. Serum homocysteine level was measured by an enzymatic method, on the instrument Hitachi 912, 
Roche, reagent: Axis-Shield Enzymatic. For proving the oxidative stress we established the level of malondialdehyde using a method 
with thiobarbituric acid TBA (Kei Satoh 1978) and the level of ceruloplasmin with the Ravin method .Also AST, ALT,CRP, iron, uric 
acid, urea were assessed. 
High level of homocysteine in both groups of study in comparison with the control group was found. The concentration of MDA was 
significantly higher in pregnancies complicated with risk of abortion and preterm birth compared to the control group (p=0.040, 
p=0.031). Considerable differences of ceruloplasmin concentration between group 1 and group 2 (p=0.045), and between group 2 
and control group (p=0.034), was noticed but not any important differences between group 1 and control group (p=0.683). 
In women with risk of abortion or with preterm birth an oxidative stress and a hyperhomocysteinemia are present. 
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Introduction 
Placental-related disorders of pregnancy affect 
around a third of human pregnancies  [1].  Changes in 
human lifestyle, such as delayed childbirth and diets 
customs, have increased the global incidence of 
placental-related disorders over the last decades [2]. 
Oxidative stress in utero–placental tissues plays an 
important role in the development of placental-related 
diseases. 
Homocysteine, a sulfur-containing amino acid 
derives from the demethylation of methionine during DNA 
or/and RNA methylation. Increased homocysteine levels 
represent a risk factor in cardiovascular disease, 
osteoporosis, renal failure, diabetic microangiopathy, 
neuropsychiatric disorders [3]. 
Maternal hyperhomocysteinemia (Hcy) is frequently 
associated  with placental mediated diseases, such as 
preeclampsia, spontaneous abortion and placental 
abruption [4].  Hyperhomocysteinemia induces the 
activations of NADPH oxidase and increases ROS [5]. 
For preventing hyperhomocysteinemia a lot of 
vitamins are prescribed during pregnancy. The folates 
belong to the vitamin B group and are involved in a large 
number of biochemical processes, including the 
metabolism of homocysteine. It is well known that folic 
acid supplementation impedes the neural tube defects, 
spontaneous abortion and recurrent pregnancy loss. 
In spite of the acknowledged harmful effect of 
homocysteine in pregnancy, a lot of questions and 
problems remain unanswered and unsolved. 
In our study we tried to estimate the clinical 
usefulness of the detection of the serum homocysteine 
and malondialdehyde in the placental related diseases 
and to evaluate the correlations between these markers in 
women with risk of abortion or preterm birth. 
Material and method 
The study was performed at the Obstetric 
Gynecology Clinical Hospital Oradea from December Journal of Medicine and Life Vol. 5, Issue 1, January‐March 2012 
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2009 until april 2010. It included 18 patients with risk of 
abortion (group 1), 22 with risk of preterm birth (group 2). 
The control group was matched with the studied groups 
for age, BMI (body mass index) and gestational age and 
consisted of 14 healthy pregnant women (group 3). All 
groups took oral vitamins supplementation which 
comprised 800 µg folic acid, 4.0 µg B12, 2.6 mg B6. 
The diagnosis of risk of abortion is made for 
pregnancies less than 24 weeks of gestation, with uterine 
contractility and with local modifications based on 
changes in the Bishop score. 
The risk of premature birth appears between 24 and 
37 weeks of pregnancies, with painful uterine contractions 
(more than 3-4 contractions per hour) and local changes 
of the cervix, that are illustrated on a modified Bishop 
score. 
For each of the patients enrolled we have a file with: 
  age, residency, living conditions, profession, studies, 
toxics (smoking and caffeine ingestion) 
  gestational age using last menstrual period and 
ultrasound confirmation 
  waist, weight, calculated BMI 
  blood pressure and sitting pulse 
  a physical examination and a gynecological one 
  an obstetrical ultrasound investigation for fetal 
biometry, viability, gestational age, biparietal diameter, 
head circumference, abdominal circumference, femur 
length.  
  a Doppler examination on uterine artery, umbilical 
artery and medial cerebral artery 
All groups were enrolled in the study after having 
been informed and subscribed a written consent. The 
study was approved by the institutional ethical committee. 
For each of the patients blood samples were 
collected from antecubital veins of the subjects in supine 
position before any medication, with all aseptic 
precautions after an overnight fasting. Samples were 
centrifuged and serum was separated and stored at -35ºC 
until analysis. 
Serum homocysteine level was measured by an 
enzymatic method, on instrument Hitachi 912, Roche, 
reagent: Axis-Shield Enzymatic Homocysteine Assay Cat 
No.FHER100. For proving the oxidative stress we 
established the level of malondialdehyde using a method 
with thiobarbituric acid TBA (16) and the level of 
ceruloplasmin with the Ravin method. In the same time 
the level of AST/GOT, ALT/GPT, CRP(C reactive protein), 
iron, uric acid and urea was tested. Data are expressed 
as mean ± SD (standard deviation). The significant 
differences was assessed using the Student`s test. P 
value < 0.05 was considered statistically significant. The 
correlation between parameters was estimated by 
Pearson`s correlation coefficient (r). 
Results 
There were no significant difference between 
gestational age, arterial pressure and body mass index 
(BMI) among the studied pregnant women and the control 
group (Table 1). The mean levels of serum homocysteine, 
MDA, ceruloplasmin, AST, ALT, CRP, iron, uric acid, urea 
are shown in table no.1. 
 
Table 1. Characteristics of study and control group 
  Group 1  Group 2  Control group 
N  18  22  14 
Age (years)  27,8±2,6  28,4±3,0  29,2±4,3 
Mean arterial pressure (mmHg)  112/70  113/72  116/73 
BMI(body mass index )  23,93  28,44  27,72 
AST/GOT(U/L)  16,66±1,32  14,47±2,09  13,23±1,78 
ALT/GPT(U/L)  10,90±1,58  10,30±2,26  10,98±2,18 
Ureea (g/L)  0,12±0,05  0,12±0,02  0,17±0,02 
Uric acid (mg/dL)  2,59±0,35  2,87±0,58  3,08±0,64 
Iron (g/dL)  87,13±22,45  70,08±21,31  65,36±10,63 
CRP (mg/L)  4,95±2,93  3,20±2,27  2,07±0,48 
Homocysteine (mol/L)  5,33±0,66  5,70±0,72  4,91±0,67 
Malondialdehyda (nmol/ml)  2,59±0,38  2,82±0,41  2,46±0,35 
Ceruloplasmin (mg/dl)  48,63±6,08  44,76±4,99  49,55±8,15 
group 1= risk of abortion, group 2= risk of preterm birth, group 3= healthy pregnant women Journal of Medicine and Life Vol. 5, Issue 1, January‐March 2012 
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In the first group of women with risk of abortion 
homocysteine concentration was higher compared to the 
control group (from 4.91μmol/l in control group to5.33 
μmol/l in group 1). The group of women with risk of 
preterm birth had also an elevated level of the seric 
homocysteine (5.70μmol/l and 4.91μmol/l in the reference 
group). Homocysteine concentration between group 1 and 
group 2 (p=0.05), between group 1 and control group 
(p=0.041), and between group 2 and control group 
(p=0.022) is statistically remarkable. 
We have obtained higher values for pregnancies 
with risk of preterm birth than for those with risk of 
abortion (Fig.  1). 
 
 
 
 
 
 
The mean values for MDA was 2.82 nmol/ml in 
pregnant women with risk of preterm birth, 2.59 nmol/ml in 
women with risk of abortion and the smallest value 2,46 
nmol/ml in the control group. There are no important 
differences between group 1 and control group (p>0.05), 
but the difference is significant between group 2 and 
group 1, respectively the control group (p=0.040, 
p=0.031). 
We obtained the smallest value for the control group 
and the highest one in the group of women with risk of 
preterm birth, but without statistical importance. There is a 
considerable variation between the women with risk of 
preterm birth, with higher MDA value than those in the 
group of women with risk of abortion (Fig.  2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We obtained important differences of ceruloplasmin 
between group 1 and group 2 (p=0.045), and between 
group 2 and the control group (p=0.034), and no 
significant differences between group 1 and the control 
group (p=0.683) (Fig.  3). 
 
 
 
 
 
 
The mean levels of CRP is higher in group in 
comparison with the group 2 (p=0.042), and also group 2 
likened with the control group (p=0.030). 
Fig.  1 Values of homocysteine in women with risk of 
abortion and risk of preterm birth compared with the control 
group 
Fig.  2 Values of MDA in women with risk of abortion or 
preterm birth compared with the control group 
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Fig. 3 Values of ceruloplasmin in women with risk of 
abortion or risk of preterm birth compared with the control 
group 
Fig.  4 Values of CRP in women with risk of abortion and 
preterm birth compared with the control group Journal of Medicine and Life Vol. 5, Issue 1, January‐March 2012 
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Variations without importance of urea and uric acid 
are present between group1, group 2 and the control 
group (p>0.05) (Table 1). The level of ALT/GPT is similar 
in all the three groups (p>0.05). Significant differences of 
the concentration of AST/GOT between group 1 and 
group 2 (p=0.011), between group 1 and the control group 
(p<0.001), appeared but not between group 2 and the 
control group (p=0.593) (Fig.  5). 
 
 
 
 
 
 
 
 
 
 
 
 
Significant negative correlations were observed 
between serum concentration of ceruloplasmin and MDA 
r=-0.71, p<0.001(Fig.  6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Significant negative correlation were observed 
between serum concentration of homocysteine and CRP 
r=-0.37, p=0.044 (Fig.  8). 
Discussion 
Due to the perturbations in methionine metabolism, 
hyperhomocysteinemia during pregnancy is implicated in 
adverse outcomes such as neural tube  defects, 
preeclampsia, spontaneous abortion, and premature 
delivery [6]. 
In our study serum homocysteine concentration was 
significantly high in both groups of women with risk of 
abortion and with the risk of preterm birth compared to the 
control. The level of homocysteine was considerably 
increased in the group of women with risk of preterm birth 
compared to the reference group (p=0.022) and also in 
the group of women with risk of abortion. 
The serum concentration of homocysteine was 
higher in the group 2 in comparison with group 1 
Fig.  5 Values of AST (GOT)/ALT (GPT) in women with risk 
of abortion and preterm birth compared with the control 
group 
Fig.  6 Correlation between ceruloplasmin and MDA 
A significant positive correlation can be seen between 
serum concentration of homocysteine and uric acid r=0.58, 
p=0.01 in figure 7. 
Fig.  8 Correlation between homocysteine and CRP Journal of Medicine and Life Vol. 5, Issue 1, January‐March 2012 
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(p=0.05).Our results were similar to those obtained by 
other researchers [7,8]. 
All the patients received a vitamin supplementation, 
having role in the prevention of homocysteinemia and of 
premature vascular disease in pregnant women. Early 
damage to decidual or corionic vessels may cause 
abnormal implantation of the blastocyst. On the other 
hand some papers point out that the disturbed folate 
metabolism is not an apparent risk factor for spontaneous 
first-trimester pregnancy loss [9]. More specific studies 
regarding type of vitamin and its usefulness need to be 
conducted. 
A significant positive correlation can be seen 
between serum concentration of homocysteine and uric 
acid. The explanation of this is that homocysteine induces 
endothelial cells lesions and release purine nucleotides. 
Catabolism of the purine nucleotides leads finally to the 
production of uric acid. Uric acid is one of the plasma 
antioxidants which protect the cells against increased 
ROS activity. 
Significant negative correlations were observed 
between serum concentration of homocysteine and CRP. 
Homocysteine is a potent excitatory 
neurotransmitter that binds to the N-methyl-D-aspartate 
(NMDA) receptor and also leads to oxidative stress, 
cytoplasmic calcium influx, cellular apoptosis, and 
endothelial dysfunction [10]. 
There are a lot of researches which put in evidence 
that oxidative stress in utero–placental tissues with an 
important role in the development of placental-related 
diseases.  
Ezashi et al. 2005 [11], pointed out that the hypoxia 
is necessary to maintain stem cells in a fully pluripotent 
state. Physiological level of reactive oxygen species 
regulates the transcription factors [12]. In normal 
pregnancies, the earliest stages of the fetus development 
take place in a physiological hypoxia. This protects the 
developing fetus against the deleterious and teratogenic 
effects of reactive oxygen species (ROS). 
In women with risk of abortion, the development of 
the placento–decidual interface is severely impaired 
leading to early and widespread onset of maternal blood 
flow and major oxidative damage. This mechanism is 
common to all miscarriages, especially in the first 
trimester of pregnancy depending also on the etiology [1]. 
The levels of lipid peroxides are too increased in the 
villous and decidual tissues of women undergoing early 
pregnancy loss [13,14]. 
In our study there are no significant differences of 
MDA between group1 and control group (p>0.05), but 
they appears between group 2 and reference group 
(p=0.031) and also significant between the studied 
groups. 
Baxter et al. [15] have shown that women with 
naturally higher levels of antioxidant enzymes are less 
likely to miscarry. The concentration of ceruloplasmin in 
the group of women with risk of abortion was considerably 
higher than in the group of women with risk of preterm 
birth (p=0.045), in comparison with healthy pregnant 
women (p=0.034). Similar values was noticed in the group 
1 and the control group (p=0.683). 
The enzyme AST/GOT catalyzes the transfer of the 
amino group of the aspartic acid to α ketoglutaric acid, 
forming glutaminic and oxaloacetic acid. After extensive 
tissue destruction AST/GOT and ALT/GPT are liberated 
into the serum. The elevated serum level of AST/GOT in 
the group of women with risk of abortion indicates an 
utero-placental damage. 
C-reactive protein (CRP) rises in the early phase of 
inflamation. The higher value of CRP associated with 
increased concentration of AST/GOT, oxidative stress 
and hiperhomocysteinemia represents a signal of severe 
utero-placental disturbance. 
These results offer arguments for an early 
prophylaxis with antioxidant vitamins which decreases 
homocysteine levels, oxidant activity and in the same time 
can restore the endothelial malfunction. 
Conclusions 
1. Serum homocysteine concentration was 
significantly higher in both groups of women with abortion 
risk and of preterm birth compared with the control group. 
 
2. A significant positive correlation can be seen 
between serum concentration of homocysteine and uric 
acid demonstrating indirectly the harmful action of 
hiperhomocysteinemia upon the endothelium. 
 
3. In both studied groups there was an 
augmentation of MDA in comparison with the control 
group. 
 
4. The rise of AST/GOT and of CRP in women with 
risk of abortion constitutes an indicator of utero-placental 
disorders. 
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